21 – 30 of 222
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Too much too late? : Optimizing treatment through conversations over years, months, and days
- Contribution to journal › Debate/Note/Editorial
- 2020
-
Mark
A Nordic-Baltic perspective on indications for proton therapy with strategies for identification of proper patients
- Contribution to journal › Article
-
Mark
Neoadjuvant breast cancer treatment response; tumor size evaluation through different conventional imaging modalities in the NeoDense study
- Contribution to journal › Article
-
Mark
Desloratadine and loratadine stand out among common H1-antihistamines for association with improved breast cancer survival
- Contribution to journal › Article
- 2019
-
Mark
Lymphovascular space invasion as a predictive factor for lymph node metastases and survival in endometrioid endometrial cancer - a Swedish Gynecologic Cancer Group (SweGCG) study
- Contribution to journal › Article
-
Mark
Diagnostic spectrum and time intervals in Sweden's first diagnostic center for patients with nonspecific symptoms of cancer
- Contribution to journal › Article
- 2017
-
Mark
Vasoactive peptides associate with treatment outcome ofbevacizumab-containing therapy in metastatic colorectal cancer
- Contribution to journal › Article
- 2016
-
Mark
Very low rate of circulating tumour cells (CTCs) in patients with PSA recurrence after radical prostatectomy referred to salvage radiotherapy.
- Contribution to journal › Letter
-
Mark
Increased risk of male cancer and identification of a potential prostate cancer cluster region in BRCA2.
- Contribution to journal › Article
-
Mark
Prognostic effect of hENT1, dCK and HuR expression by morphological type in periampullary adenocarcinoma, including pancreatic cancer.
- Contribution to journal › Article
